NNIT’s new CEO is all in
Pär Fors was on sabbatical, contemplating his next executive challenge when he was approached by NNIT’s Board of Directors. As talks progressed, it became clear that NNIT fit the bill: a CEO role within the tech industry, in a company with a clear and ambitious strategy for international expansion, but slightly different to other players due to its focus on life science.
Financial results for Q1 2021 just released: Group revenue up 1.2%
In Q1, we experienced continued strong growth within the International Life Sciences business, with Excellis performing to plan. Our Private & Public business started to see positive momentum in relation to the Winning Solutions strategy, which now constitutes 49% of NNIT’s revenue.
Lonza and NNIT partner to speed up MES projects
Across the life sciences industry, pharma companies are seeking new ways to respond to the high agility required to produce complex products like personalized cancer treatment, cell and gene therapy and Covid-19 vaccines. Central to these efforts is the manufacturing execution system (MES), which allows pharma companies to adopt pharma 4.0 production and manage their data flows to expedite product
NNIT to support COVID-19 vaccine safety data capture
NNIT, a trusted partner of AstraZeneca’s since 2014, will be implementing the critical COVID-19 vaccine post-marketing safety data system.
Acquisition-boosted Orifarm selects NNIT as new strategic IT partner
Orifarm and NNIT have signed a contract for the delivery of end-to-end IT services in connection with Orifarm’s acquisition of a significant portfolio of select over-the-counter (OTC) and prescription pharmaceutical products from Japanese pharmaceutical giant Takeda.
NNIT signs largest Veeva deal to date
NNIT recently signed its largest Veeva deal to date with a global top-10 life sciences company.
An expert in transition and transformation
NNIT’s new CFO, Pernille Fabricius, is a change management enthusiast: “I welcome and embrace change, and I enjoy leading an organization through a transformation process to stimulate growth and lasting value across the board. That’s what I’ve been doing throughout my career, and it’s what motivates me”.
NNIT and BA Insight partner to accelerate clinical trials
NNIT and BA Insight enters new partnership
NNIT Group acquires Excellis Health Solutions and continues its Life Sciences growth journey
NNIT acquires US-based Excellis, a leading specialized global provider in end-to-end supply chain consulting services to the life sciences industry.
Introducing NNIT Singapore
Following the acquisition of HGP in April 2019 and due legal processes, HGP’s Asia branch recently became NNIT Singapore Pte Ltd.
NNIT and Association of Danish Pharmacies extend collaboration
NNIT extends twelve-year collaboration another four years.